GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » 12-1 Month Momentum %

Nortem Biogroup (XPAR:MLBIO) 12-1 Month Momentum % : N/A% (As of Jun. 21, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-06-21), Nortem Biogroup's 12-1 Month Momentum % is N/A%.

The industry rank for Nortem Biogroup's 12-1 Month Momentum % or its related term are showing as below:

XPAR:MLBIO's 12-1 Month Momentum % is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: -0.46
* Ranked among companies with meaningful 12-1 Month Momentum % only.

Competitive Comparison of Nortem Biogroup's 12-1 Month Momentum %

For the Packaged Foods subindustry, Nortem Biogroup's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nortem Biogroup's 12-1 Month Momentum % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Nortem Biogroup's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Nortem Biogroup's 12-1 Month Momentum % falls into.



Nortem Biogroup  (XPAR:MLBIO) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nortem Biogroup  (XPAR:MLBIO) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Nortem Biogroup 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nortem Biogroup (XPAR:MLBIO) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500
Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines